Abstract:The basic principle of bone induction for tissue engineering is to use stem cells, growth factors and organic matrix. KUSA/A1 cell is an example of bone marrow stromal stem cell, capable of differentiating into osteoblasts, chondrocytes and myotubes under inducing conditions. It has been reported that mature KUSA/A1 osteoblasts cultured in osteogenic condition, were able to induce a few bone formation in collagen hybridized PLGP sponge in vivo. This may be due to their low proliferation potential thereby not being able to obtain sufficient number of cells to promote large tissue repair.
Introduction
Bone regeneration is a biological process to renew damaged bone tissue. Autografts, bone obtained from another site of the same subject, are currently the gold standard for bone repair and substitution, but the use of autografts has several serious disadvantages, such as additional expense and trauma to the patient, the possibility of donor-site morbidity, and importantly limited availability 1, 2) . Because of these problems, bone tissue engineering has been heralded as an alternative strategy for bone regeneration [3] [4] [5] . However, some strategies used in this method have demonstrated inflammatory reaction 6) , few amount of bone formation in old age 7) , and high risk of tumor formation 8) .
Recent progress in tissue engineering offers the prospect of sophisticated physiological in vitro models with the aim of developing materials that will help the body to heal itself.
Temporary three-dimensional scaffolds play an important role in the manipulating the functions of osteoblasts 9) and guiding new bone formation in their desired shapes 10, 11) . These scaffolds should be biocompatible, osteoconductive, biodegradable, highly porous with a large surface-to-volume ratio, mechanically strong, and malleable into the desired shapes 12) . Collagen is the primary component of extracellular bone matrix and has been demonstrated to produce good osteoconductivity 13) . Atelocollagen is produced by telopeptides removal from natural collagen molecules resulting to extremely low antigenicity 14) . It is most widely used as a wrinkle eraser by injecting it into the skin 15) . Atelocollagen is also used as a scaffold for keratinocytes and fibroblasts in artificial skin 15) . It is even used to minimize allergic reactions in cosmetics 16) . In the present study, we selected atelocollagen type I honeycomb scaffold because it has high cell affinity, and maintains its structural integrity, original size and shape during cell growth in vitro 17) .
This scaffold could enhance bone regeneration allowing high cellular proliferation and differentiation at the same time maintain the precise size and shape of the newly formed bone in vivo.
Recently, implantation of cells on scaffold has taken a great importance in tissue engineering and is expected to provide new applications for the creation of new organs and tissues. KUSA/ A1 cells are marrow stromal cell line from primary bone marrow culture of female C3H/He mouse, which possess osteoblastic properties in vivo. Immortalized cells were obtained by frequent subculture for more than a year 18) . Moreover, mature KUSA/A1
osteoblasts cultured in osteogenic medium were able to induce few bone formation in collagen hybridized PLGP sponge in vivo 12) .
This may be due to their low proliferation potential thereby not being able to obtain sufficient number of cells to promote large tissue repair. Because of this, in order to use KUSA/A1 cells with high cell proliferation activity to induce large amount of new bone, the biological analysis of KUSA/A1 cells for bone tissue engineering in vitro and in vivo condition was performed.
Materials and Methods

Experiment I
In order to use KUSA/A1 cells with high cell proliferation activity to induce large amount of new bone, we evaluated whether KUSA/A1 cells in non-induction condition will maintain their immature stage.
Cell isolation (prepared by Dr. Umezama A.)
Primary culture of the marrow cells was performed according to Dexter's method 19) . Female C3H-He mice (n=10) were anesthetized with ether, femurs were excised, and bone marrow cells were obtained for primary bone marrow cultures. Cells were cultured in Iscove's modified Dulbecco's medium (IMDM)
supplemented with 20% fetal bovine serum (FBS) and penicillin (100 mg/ml)/streptomycin (250 ng/ml) at 37ºC in humid air with 5% CO2. Immortalized cells were obtained by frequent subculture for more than a year. Cell lines from different dishes were subcloned by limiting dilution.
Cell culture
KUSA/A1 cells were courtesy of Dr. A. Umezawa from Keio University, Tokyo, Japan. The cells were cultured in minimum essential medium alpha medium (α-MEM, GIBCO BRL, Inc., USA) supplemented with 10% FBS (SIGMA, USA) and 1%
antibiotic-antimycotic agent (GIBCO, USA). Then, they were seeded in 10cm petridishes (Falcon, Inc., USA) and incubated at 37ºC in humid air with 5% CO2.
In order to induce cell differentiation in vitro, the cells were exposed to ascorbic acid (AA, 50 mg/ml) and β-glycerophosphate (β-GP 6 mM). The growth medium was changed every 3 days until the cells were nearly confluent. The cells were analyzed at 1, 3, 7, 10 and 14 days by Von Kossa staining and also paraffin embedded cell pellets were prepared for hematoxylin-eosin staining (H-E) and immunohistochemical studies (Fig.1 ).
Experiment II
In order to examine the osteoblastic differentiation under the influence of the host microenvironment, KUSA/A1 cells were seeded in diffusion chamber and implanted in the peritoneal cavity.
Diffusion Chamber implantation
Twelve SCID mice were subjected to intramuscular anesthesia with Nembutal (Dianabot, USA). The ventral surface of the skin was shaved, disinfected with 70% alcohol and iodine and cut by blunt dissection to form peritoneal pockets. 5x10 6 of KUSA/A1 cells were placed in 6 diffusion chambers, and implanted in the peritoneum. The animals were sacrificed with an overdose of ether at 1, 2, 4 and 6 weeks after implantation. The chambers were removed, fixed with 4% paraformaldehyde (PFA), embedded in paraffin, sectioned at 4 µm in thickness, and stained with routine The cell pellets were removed to plastic vial. 3: Then, they were prepared for paraffin block. 4: Finally, they were sectioned at 4mm in thickness and stained. Fig.2 . Scheme of in vivo cell culture method. The cells were seeded in diffusion chambers and implanted in the peritoneal cavity. The animals were sacrificed at 1, 2, 4 and 6 weeks after implantation. The implants were subjected to H-E staining, Von Kossa staining and TEM.
H-E, Von Kossa staining and immunohistochemical studies (Fig.2) .
Transmission electron microscopy (TEM)
The chambers were fixed with 2% glutaraldehyde and 2%
PFA buffer with a pH of 7.4 for 2 hours at 4 o C, postfixed in 2%
OsO4 buffer with pH of 7.4 for 2 hours at 4 o C, then dehydrated in ethanol series and embedded in EPON 812. Ultrathin sections were cut with a diamond knife using Reichert Ultracute Microtome (Germany). The sections were stained with 2% uranylacetate and nitrate and examined using H-800 TEM.
Experiment III
In order to evaluate the effect of honeycomb scaffold to induce abundant bone formation, KUSA/A1 cell alone and combined with atelocollagen honeycomb scaffold were implanted in subcutaneous tissue of mice.
Atelocollagen honeycomb scaffold
The atelocollagen honeycomb scaffold (KOKEN, Japan), 3x3x2 mm in size, composed by multiple collagen membranes (1mm in thickness) with honeycomb-shaped were used. The scaffold is composed of parallel pores extended from surface to surface (Fig. 3A) .
Three-dimensional culture
When the cells became nearly confluent (Fig. 3B ), they were harvested with trypsin-EDTA and placed at a concentration of 2x10 5 cell/ml onto atelocollagen honeycomb scaffold in suspension culture treated dishes. The cells were grown for 10 days at 37ºC in humid air with 5% CO 2. The medium was changed every 3 days (Fig. 3C, D) . 3 paraformaldehyde and subjected to soft X-ray (SOFTEX). Then, they were decalcified with 10% EDTA, embedded in paraffin, sectioned at 4 mm in thickness, and stained with H-E. The implants were also subjected to immunohistochemical studies (Fig. 4) .
Immunohistochemical staining of CD34, Proliferating Cell Nuclear Antigen (PCNA), and Osteopontin (OSP)
The sections were immunostained with monoclonal antibodies against CD34 (Abcam.UK) using Vectastain ABC (Adivin-Biotin- 
Immunohistochemical staining of Collagen type I (Coll I) and Osteocalcin (OSC)
The sections were also immunostained with polyclonal 
Quantification of bone induction, vessel formation and cellular proliferation
In order to clearly emphasize the efficacy of this scaffold, the quantity of the whole new bone formed in both groups was measured using NIH image. The specimens stained by CD34 and PCNA were subjected to histometrical studies at 1, 2 and 4 weeks after implantation in order to know the vessel and cellular proliferation amount, respectively. The counting process was performed by using an eyepiece micrometer at three separate areas: 4 
Non-including condition
Including condition Non-including condition Including condition 
Statistical Analysis
The statistical study was performed with SPSS for Windows Statistical program by using Student's t-test. 
Results
I. In vitro study
II. In vivo Cell culture condition
Histological analysis
KUSA/A1 cells at 1 week demonstrated evidence of multilayer of spindle-shaped cells (Fig.10 A) . KUSA/A1 cells at 2 weeks revealed early immature bone formation attached to the membrane of the chamber. Osteoid formation, osteocytes, and active osteoblasts were observed. Matrix protein secretion was also observed within the pores of the membrane (Fig.10 C) . KUSA/ A1 cells at 4 weeks showed more amount of bone with many osteocytes within the lacuna formation, osteoid and mineralized matrix. Matrix proteins were also detected within the pores of the membrane (Fig.10 E) . KUSA/A1 cells at 6 weeks revealed degenerative cells and bone (Fig.10 G) .
Calcification analysis (Von Kossa staining)
Calcium accumulation was not seen in KUSA/A1 cells at 1 week (Fig.10 B) . At 2 weeks, initial calcium deposition appeared were observed like "small spots", distinctly separate from the noncalcified areas (Fig.10 D) . The cells apart from the membrane of the chamber, and the tissue attached to the membrane of the chamber showed calcium accumulation at 4 and 6 weeks ( Fig.10 F, H ).
Immunohistochemical analysis 6 
Transmission electron microscopy
TEM was performed, in order to examine the initial calcification foci in the hard tissue induced by KUSA/A1 cells within the diffusion chamber.
Cytoplasmic processes within the membrane of the chamber and multilayer of undifferentiated KUSA/A1 cells were observed at 1 week (Fig.12 A, B) . The initial calcification foci were seen in the collagen fiber and also in the matrix vesicles within the membrane of the diffusion chamber at 2 weeks (Fig.12 C, D) .
Dystrophic calcification was also detected in degenerated cells apart from the membrane of the chamber at 4weeks (Fig.12 E, F) .
In vivo study
Radiological examination
At 1 week, both groups revealed weak radiopacity areas (Fig.13A, B) . At 2 weeks, KUSA/A1-Atelocollagen implants showed many weakly spotted areas of diffuse and wide radiopacities (Fig.13 C) . In KUSA/A1 alone implants revealed a weak and small radiopaque area (Fig.13 D) . At 4 weeks, in KUSA/ A1-Atelocollagen, the scaffolds were filled with many ovoid or rounded radiopaque areas showing different degrees of calcification with unclear or diffuse border (Fig.13 E) . KUSA/ Collagen I Osteocalcin Ostepontin A1 alone showed irregular radiopaque areas. The radiopacities were homogeneous and dense with well-defined border (Fig.13 F) .
Histological Examination
KUSA/A1-Atelocollagen at 1 week
The implants demonstrated scanty immature bone formation at the periphery of the scaffold (Fig.14 A) . Areas with several amount of cell debris without vessel formation were noted.
However, evidence of other areas with vessel formation and healthy cells were also observed.
KUSA/A1 alone at 1 week
The transplants exhibited small islands of immature bone formation surrounded by proliferating KUSA/A1 cells. (Fig.14 B) 
KUSA/A1-Atelocollagen at 2 weeks
The specimens showed three different areas: 1) cellular proliferation and vessel formation, 2) few cells with many vessels formation, and 3) more woven bone formation (Fig.14 C) . The newly formed bone was present on scaffold collagen membranes, but not attached. The immature bone formation was seen especially at the periphery of the scaffold. Muscle and fat tissues were also detected.
KUSA/A1 alone at 2 weeks
The samples showed few small islands of new bone formation, some surrounded by KUSA/A1 cell proliferation (Fig.14 D) . Inside the new bone, osteocytes as well as many vessels were observed.
Fat and connective tissue were also detected.
KUSA/A1-Atelocollagen at 4 weeks
The slides showed scaffolds filled with new bone and high cellularity (Fig.14E) . The newly formed hard tissue was observed at the scaffold periphery and cellular proliferation was found in the center .The newly formed bone was composed of irregular trabeculae bordered by active osteoblasts, and osteocytes were seen within the bone matrix.
KUSA/A1 alone at 4 weeks
The specimens showed islands of new bone surrounded by a thin layer of cells (Fig.14F) . Bone was composed by lamellae irregular rings and populated by a variable number of osteocytes within the lacunae as well as vessel formation. Loose connective tissue, fat and muscle were also seen. Note that the newly formed bone is more immature in KUSA/A1-Atelocollagen than in KUSA/ A1 alone.
Immunohistochemical examination of KUSA/A1-Atelocollagen at 1 week
Presence of areas with cell debris without vessel formation ( Fig.15A atage 1) , areas with few cells with many developing vessels strongly positive for CD34 and areas with high cellularity intensely positive for PCNA were observed. KUSA/A1-Atelocollagen KUSA/A1 cell alone 
KUSA/A1 alone at 1 week
Small islands of immature bone formation surrounded by proliferating cells positive for PCNA and also evidence of many vessel formations intensely positive for CD34 were seen.
KUSA/A1-Atelocollagen at 2 weeks
Excessive developing vessels within the pore of the scaffold showing positive immunoreaction for CD34 were observed ( Fig.15A stage 2 ). In areas with high cellular proliferation, many nuclei were strongly positive for PCNA (Fig.15A stage 3 ).
However, Coll I and OSP, were negative. OSC was generally negative though few cells showed positive reaction. Central nucleations of mineralization in areas with high cellularity, which are intensively positive for OPN were observed (Fig.15B stage 3 ).
In areas with bone formation, differentiated osteoblasts and young osteocytes were positive for Coll I and OSC, while the bone matrix was weakly positive for Coll I. The mineralized front was positive for OSP. Moreover, at woven bone and low cellular proliferation areas, many endothelial cells were clearly positive for CD34.
KUSA/A1 alone at 2 weeks
Few small vessels were positive for CD34. Some KUSA/A1 cells surrounding the hard tissue were positive for PCNA.
However, these cells were negative for OSP and weakly stained 
KUSA/A1-Atelocollagen at 4 weeks
In areas with bone formation, differentiated osteoblasts and young osteocytes were positive for Coll I and OSC. Bone matrix was weakly positive for Coll I (Fig.15B stage 4,5) . The mineralized fronts were strongly positive for OSP (Fig.15B stage 4 
Quantification of bone induction, vessel formation and cellular proliferation in KUSA/A1 alone and KUSA/A1-Atelocollagen
The areas of the new bone formation are 36, 170 and 268 9 alone, although the change at 4 weeks was not dramatic (Fig.16C) .
Thus, KUSA/A1 cells combined with this scaffold type showed a significant increase in vessel formation at 1, 2 weeks (*P = 0.0010) and 4 weeks (**P < 0.0001) as well as cellular proliferation both at 2 weeks (**P < 0.0001) and 4 weeks (* P = 0.0079). Note that vessel formation and cellular proliferation in KUSA/A1 cells alone In KUSA/A1-Atelocollagen, the number of vessels was significantly higher and different compared with KUSA/A1 alone at 1 and 2 (*P=0.0010) and 4 weeks (*P < 0.0001). C: Effects of Atelocollagen honeycomb scaffold on cellular proliferation marked with PCNA Student's t-test. In KUSA/A1-Atelocollagen, cells positively stained for PCNA was significantly higher and different compared with KUSA/A1 alone at 2 (**P < 0.0001) and 4 weeks (** P = 0.0079).
at 2 and 4 weeks were almost the same.
Discussion
KUSA/A1 cells have been isolated from adult marrow and are capable to differentiate into osteoblast, chondrocytes and myotubes under inducing condition 18) . Thus, KUSA/A1 after cultured in osteogenic condition (composed by ascorbic acid and b-glycerophosphate), expressed high ALP activity, calcium deposition, osteocalcin release with low PTH responsibility 20) . It has been reported that ascorbic acid is required for the synthesis of collagen, the regulation of alkaline phosphatase activities and protein synthesis in cultures of osteoblasts-like cells 21) . The organic phosphate, β-glycerophosphate, has been used in vitro to provide a potential source of phosphate ions 21) . 22) . In order to evaluate the cell differentiation under the influence of the microenvironment, KUSA/A1 cells were implanted in intraperitoneal diffusion chamber. We selected intraperitoneal cavity, because in experimental animals this provides a powerful tool for studying stem cells in vivo 23) . Surprisingly, KUSA/A1 cells at 2, 4 and 6 weeks revealed bone formation only inside of chamber with matrix protein secretion within the pores of the membrane (Fig.10 C, E, G). We believe that the new bone was formed only by KUSA/A1 cells within the chamber, because the size of the pore in this membrane is too small (0.22 mm diameter) to permit cell migration. These new hard tissues exhibited presence of calcium deposition stained by Von Kossa (Fig.10 D, F, G) and the initial calcification foci observed by TEM, were seen in the collagen fiber of the osteoid, in the matrix vesicles within the membrane of the diffusion chamber ( Fig.12 C, D) and also degenerated cells apart from the membrane of the chamber at 4weeks (Fig.12 E, F) .
Moreover, the new bone showed immunopositive reaction for osteogenic markers (Fig.11) . These results suggest that KUSA/ A1 cells seeded within a host microenvironment are capable to differentiate into osteoblasts and produce mineralized bone matrix. [26] [27] [28] [29] . We selected atelocollagen honeycomb scaffold as a carrier, because it offers a good environment for the cells and good mechanical stability, and maintains its original size and shape during cell growth in vitro 17) . Importantly, KUSA/A1 cells on Atelocollagen scaffold were able to proliferate and differentiate into osteoblasts, followed by the degradation of the scaffold. The cells generated their own extracellular matrix, suggesting that atelocollagen honeycomb scaffold was biocompatible for KUSA/A1 cells and interfaced surrounding tissues in vivo.
Radiographically, KUSA/A1-Atelocollagen showed larger, but less degree of radiopacity compared with KUSA/A1 cells alone (Fig.13) . Histologically, KUSA/A1-Atelocollagen formed more immature bone than KUSA/A1 cells alone, suggesting that this scaffold enhanced the amount of the new bone, but needed more time to be mature bone compared to KUSA/A1 cells alone.
Moreover our study showed that the new bone formed is completely separated from the collagen membrane of the scaffold at 2 weeks. In contrast, it has been reported that, BMP-collagen carrier was important to form new bone, because most osteoid was close to the carrier fibers 30) . At 4 weeks, the whole scaffold was filled with proliferated cells and woven bone (Fig.14.E) .
Collagen membranes were absent and replaced by hard tissues.
Interestingly, the new bone was only formed into the scaffold, suggesting that this scaffold plays an important role in carrying the cells giving the precise size, shape and comfortable environment.
It is well-known that vascularization is an important prerequisite for osteogenesis 31, 32) . Atelocollagen honeycomb scaffold contains parallel tubes easily invaded by vessels in vivo.
Vascularization in the implant regions progressed with the proliferation of KUSA/A1 cells. The number of vessels, strongly positive for CD34 increased in KUSA/A1-Atelocollagen at 2 and 4 weeks (Fig.16 B) . demonstrated that after oxygen supply by vessel formation within the scaffold, the cells were able to proliferate, and preosteoblasts condense and differentiate into osteoblasts with bone matrix deposition similar to intramembranous bone formation. As it has been reported, the micromass culture indicated that cell-cell contact and cell-cell communication were important for the differentiation process 34, 35) . The micromass inoculation corresponds to the state of condensation of mesenchymal cells during membranous bone formation, which amplifies the number of pre-osteoblasts 36) . We believe that these cells are capable to form micromass-like structure within collagen membrane spaces of the scaffold that would permit cell-cell contact inducing osteoblast differentiation expressed by Coll I, OSC and OSP markers.
In summary, few KUSA/A1 cells are capable of forming large amount of new bone within honeycomb scaffold compared to KUSA/A1 cells alone (Fig.16 A) . The new bone started from the periphery of the scaffold. In KUSA/A1-atelocollagen groups, the new bone was formed only into the scaffold, whereas KUSA-A1 cells alone induced formation of many small islands of new bone in diffuse area. We speculate the sequence of bone formation by KUSA/A1 cells combined with honeycomb scaffold as follows (Fig.15A, B) .
Presence of few cells after implantation.
1.The cells became hypoxic and form cell debris due to lack of blood supply. 
